Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3875-3884

  Mangieri, Domenica ^a   Corradi, Domenico ^a   Martorana, Davide ^b   Malerba, Giovanni ^c   Palmisano, Alessandra ^a   Libri, Irene ^a   Bartoli, Veronica ^a   Carnevali, Maria L ^a   Goldoni, Matteo ^a   Govoni, Paolo ^a   Alinovi, Rossella ^a   Buzio, Carlo ^a   Vaglio, Augusto ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

chemokines; eosinophils; eotaxin CCL11; haplotype analysis; idiopathic retroperitoneal fibrosis

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR3; EOTAXIN; FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G4; INTERLEUKIN 5; PLATELET DERIVED GROWTH FACTOR; RANTES; TRYPTASE;

ABDOMINAL AORTA; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CCL11 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL INFILTRATION; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROBLAST; FIBROSIS; GENDER; GENE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC RETROPERITONEAL FIBROSIS; ILIAC ARTERY; IMMUNOGENETICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE COUNT; MALE; MAST CELL; ONSET AGE; PAIN; PERITONEAL BIOPSY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RETROPERITONEAL BIOPSY; RETROPERITONEAL FIBROSIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; URETER;

CASE-CONTROL STUDIES; CHEMOKINE CCL11; CHEMOKINE CCL5; EOSINOPHILS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENETIC ASSOCIATION STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HAPLOTYPES; HUMANS; IMMUNOGENETIC PHENOMENA; INTERLEUKIN-5; MALE; MAST CELLS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, CCR3; RETROPERITONEAL FIBROSIS;

EID: 84868523138     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs408     Document Type: Article

References (48)

1. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-251
2. Alberti C. Retroperitoneal fibroses: aetiopathogenesis and taxonomic assessment. Eur Rev Med Pharmacol Sci 2007; 11: 375-382
3. Vaglio A, Palmisano A, Corradi D et al. Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007; 33: 803-817, vivii
4. Martorana D, Vaglio A, Greco P et al. Chronic periaortitis and HLADRB1* 03: another clue to an autoimmune origin. Arthritis Rheum 2006; 55: 126-130
5. Vaglio A, Greco P, Corradi D et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev 2006; 5: 458-464
6. Vaglio A, Corradi D, Manenti L et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003; 114: 454-462
7. Corradi D, Maestri R, Palmisano A et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 2007; 72: 742-753
8. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 88-94
9. Zen Y, Onodera M, Inoue D et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009; 33: 1833-1839
10. Munitz A, Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004; 59: 268-275
11. Corradi D, Vaglio A, Maestri R et al. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 2004; 35: 1160-1163
12. Neumann T, Manger B, Schmid M et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 2009; 88: 236-243
13. Polzer K, Karonitsch T, Neumann T et al. Eotaxin-3 is involved in Churg-Strauss syndrome-a serum marker closely correlating with disease activity. Rheumatology (Oxford) 2008; 47: 804-808
14. Kobayashi H, Gleich GJ, Butterfield JH et al. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002; 99: 2214-2220
15. Rochester CL, Ackerman SJ, Zheng T et al. Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 1996; 156: 4449-4456
16. Crivellato E, Beltrami CA, Mallardi F et al. The mast cell: an active participant or an innocent bystander? Histol Histopathol 2004; 19: 259-270
17. Olsson N, Ulfgren AK, Nilsson G. Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann Rheum Dis 2001; 60: 187-193
18. Artuc M, Steckelings UM, Henz BM. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol 2002; 118: 391-395
19. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99: 1313-1321
20. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010; 125: S73-S80
21. Wasmuth HE, Tacke F, Trautwein C. Chemokines in liver inflammation and fibrosis. Semin Liver Dis 2010; 30: 215-225
22. van Bommel EF, Jansen I, Hendriksz TR et al. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 2009; 88: 193-201
23. Vaglio A, Palmisano A, Alberici F et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011; 378: 338-346
24. Altshuler DM, Gibbs RA, Peltonen L et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58
25. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575
26. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996; 97: 604-612
27. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol 2001; 22: 83-87
28. Yamashita K, Haga H, Mikami Yet al. Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis. Histopathology 2008; 52: 404-409
29. Romagnani P, De Paulis A, Beltrame C et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999; 155: 1195-1204
30. Price KS, Friend DS, Mellor EA et al. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13. Am J Respir Cell Mol Biol 2003; 28: 420-427
31. Puxeddu I, Bader R, Piliponsky AM et al. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. J Allergy Clin Immunol 2006; 117: 103-110
32. Palmisano A, Corradi D, Carnevali ML et al. Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. Clin Nephrol 2010; 74: 485-490
33. Zen Y, Fujii T, Harada K et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 1538-1546
34. Fujisawa T, Kato Y, Nagase H et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000; 106: 507-513
35. Lamkhioued B, Abdelilah SG, Hamid Q et al. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 2003; 170: 537-547
36. Gerber BO, Zanni MP, Uguccioni M et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997; 7: 836-843
37. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-2007
38. Minshall EM, Hamid QA. Fibroblasts: a cell type central to eosinophil recruitment? Clin Exp Allergy 2000; 30: 301-303
39. Zweifel M, Mueller C, Schaffner T et al. Eotaxin/CCL11 expression by infiltrating macrophages in rat heart transplants during ongoing acute rejection. Exp Mol Pathol 2009; 87: 127-132
40. Haley KJ, Lilly CM, Yang JH et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000; 102: 2185-2189
41. Ying S, Robinson DS, Meng Q et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997; 27: 3507-3516
42. Tacke F, Trautwein C, Yagmur E et al. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. J Gastroenterol Hepatol 2007; 22: 1256-1264
43. Zweifel M, Matozan K, Dahinden C et al. Eotaxin/CCL11 levels correlate with myocardial fibrosis and mast cell density in native and transplanted rat hearts. Transplant Proc 2010; 42: 2763-2766
44. Saito H. Role of mast cell proteases in tissue remodeling. Chem Immunol Allergy 2005; 87: 80-84
45. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493-499
46. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a largevessel vasculitis? Curr Opin Rheumatol 2011; 23: 1-6
47. Syversen SW, Goll GL, Haavardsholm EA et al. A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients. Arthritis Res Ther 2008; 10: R28
48. Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R et al. Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res 2010; 11: 110